Enzolytics Announces the Discovery and Patenting of Eleven Newly Identified Conserved Target Sites on the SARS-CoV-2 Virus (Coronavirus)
Production of Monoclonal Antibodies Targeting These Sites Is in Process in the Company’s Texas Lab COLLEGE STATION, TX / ACCESSWIRE / February 22, 2021 / Enzolytics, Inc. (OTC Markets “ENZC” or the “Company”) today announced it has identified eleven conserved, expectedly immutable sites (epitopes) on the Coronavirus against which it is